These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 10849461

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Weight gain and hyperglycaemia associated with olanzapine.
    Riccitelli G, Baker N.
    Aust N Z J Psychiatry; 2002 Apr; 36(2):270-1. PubMed ID: 11982558
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Olanzapine for the treatment of monosymptomatic hypochondriacal psychosis.
    Fawcett RG.
    J Clin Psychiatry; 2002 Feb; 63(2):169. PubMed ID: 11874224
    [No Abstract] [Full Text] [Related]

  • 32. Acute altered mental status in a psychiatric patient.
    Roman AM, Hughes J, Simmons HF.
    J Ark Med Soc; 2009 Nov; 106(5):110-2. PubMed ID: 19899296
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment.
    Crook JM, Tomaskovic-Crook E, Copolov DL, Dean B.
    Am J Psychiatry; 2001 Jun; 158(6):918-25. PubMed ID: 11384900
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. New antipsychotic drugs produce better outcomes.
    Healthc Benchmarks; 1997 Oct; 4(10):142-4. PubMed ID: 10173374
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Use of high-dose olanzapine in refractory psychosis.
    Reich J.
    Am J Psychiatry; 1999 Apr; 156(4):661. PubMed ID: 10200755
    [No Abstract] [Full Text] [Related]

  • 39. QTc prolongation: chlorpromazine and high-dosage olanzapine.
    Gurovich I, Vempaty A, Lippmann S.
    Can J Psychiatry; 2003 Jun; 48(5):348. PubMed ID: 12866343
    [No Abstract] [Full Text] [Related]

  • 40. Olanzapine-induced destabilization of diabetes in the absence of weight gain.
    Ramankutty G.
    Acta Psychiatr Scand; 2002 Mar; 105(3):235-6; discussion 236-7. PubMed ID: 11939979
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.